Blog | Veristat Insightful Perspectives

Contact Veristat Now


Request A Proposal

Contact Us

Regulatory Guidance Monthly Review - June 2020

June 2020 



Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA)  that are pertinent to the governance of clinical trials and drug, biologic, or medical device development and approval.   Below are the relevant links to updates provided for both COVID-19 related and non-COVID-19 related programs in June 2020.

 

Read More